Leptin has a potential dual role in the initiation and progression phases of MASLD.In the initial stages of the disease, leptin has an anti-steatotic effect, but asMASLD progresses and leptin levels increase above normal levels, it exerts aproinflammatory and profibrogenic action (34). The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.